CHAPTER 1. Industry Overview of Complementary and Alternative Medicine Market
1.1. Definition and Scope
1.1.1. Definition of Complementary and Alternative Medicine
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Complementary and Alternative Medicine Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Complementary and Alternative Medicine Market By Type
1.2.3. Complementary and Alternative Medicine Market By Disease
1.2.4. Complementary and Alternative Medicine Market By Distribution Channels
1.2.5. Complementary and Alternative Medicine Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Complementary and Alternative Medicine Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Complementary and Alternative Medicine Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Complementary and Alternative Medicine Market By Type
5.1. Introduction
5.2. Complementary and Alternative Medicine Revenue By Type
5.2.1. Complementary and Alternative Medicine Revenue (USD Million) and Forecast, By Type, 2020-2032
5.2.2. Traditional Alternative Therapeutics
5.2.2.1. Traditional Alternative Therapeutics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Body Therapy
5.2.3.1. Body Therapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Mind Therapy
5.2.4.1. Mind Therapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Sensory Therapy
5.2.5.1. Sensory Therapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.6. Others
5.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Complementary and Alternative Medicine Market By Disease
6.1. Introduction
6.2. Complementary and Alternative Medicine Revenue By Disease
6.2.1. Complementary and Alternative Medicine Revenue (USD Million) and Forecast, By Disease, 2020-2032
6.2.2. Cancer
6.2.2.1. Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Arthritis
6.2.3.1. Arthritis Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Diabetes
6.2.4.1. Diabetes Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Cardiovascular
6.2.5.1. Cardiovascular Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.6. Neurology
6.2.6.1. Neurology Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.7. Others
6.2.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Complementary and Alternative Medicine Market By Distribution Channels
7.1. Introduction
7.2. Complementary and Alternative Medicine Revenue By Distribution Channels
7.2.1. Complementary and Alternative Medicine Revenue (USD Million) and Forecast, By Distribution Channels, 2020-2032
7.2.2. Direct Sales
7.2.2.1. Direct Sales Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Online Sales
7.2.3.1. Online Sales Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Distance Correspondence
7.2.4.1. Distance Correspondence Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Complementary and Alternative Medicine Market By Country
8.1. North America Complementary and Alternative Medicine Market Overview
8.2. U.S.
8.2.1. U.S. Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
8.2.2. U.S. Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
8.2.3. U.S. Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
8.3. Canada
8.3.1. Canada Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
8.3.2. Canada Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
8.3.3. Canada Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Complementary and Alternative Medicine Market By Country
9.1. Europe Complementary and Alternative Medicine Market Overview
9.2. U.K.
9.2.1. U.K. Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
9.2.2. U.K. Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
9.2.3. U.K. Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
9.3. Germany
9.3.1. Germany Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
9.3.2. Germany Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
9.3.3. Germany Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
9.4. France
9.4.1. France Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
9.4.2. France Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
9.4.3. France Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
9.5. Spain
9.5.1. Spain Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
9.5.2. Spain Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
9.5.3. Spain Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
9.6.2. Rest of Europe Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
9.6.3. Rest of Europe Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Complementary and Alternative Medicine Market By Country
10.1. Asia Pacific Complementary and Alternative Medicine Market Overview
10.2. China
10.2.1. China Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
10.2.2. China Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
10.2.3. China Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
10.3. Japan
10.3.1. Japan Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
10.3.2. Japan Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
10.3.3. Japan Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
10.4. India
10.4.1. India Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
10.4.2. India Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
10.4.3. India Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
10.5. Australia
10.5.1. Australia Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
10.5.2. Australia Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
10.5.3. Australia Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
10.6. South Korea
10.6.1. South Korea Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
10.6.2. South Korea Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
10.6.3. South Korea Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
10.7.2. Rest of Asia-Pacific Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
10.7.3. Rest of Asia-Pacific Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Complementary and Alternative Medicine Market By Country
11.1. Latin America Complementary and Alternative Medicine Market Overview
11.2. Brazil
11.2.1. Brazil Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
11.2.2. Brazil Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
11.2.3. Brazil Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
11.3. Mexico
11.3.1. Mexico Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
11.3.2. Mexico Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
11.3.3. Mexico Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
11.4.2. Rest of Latin America Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
11.4.3. Rest of Latin America Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Complementary and Alternative Medicine Market By Country
12.1. Middle East & Africa Complementary and Alternative Medicine Market Overview
12.2. GCC
12.2.1. GCC Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
12.2.2. GCC Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
12.2.3. GCC Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
12.3. South Africa
12.3.1. South Africa Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
12.3.2. South Africa Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
12.3.3. South Africa Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Type, 2020-2032
12.4.2. Rest of Middle East & Africa Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Disease, 2020-2032
12.4.3. Rest of Middle East & Africa Complementary and Alternative Medicine Revenue (USD Million) and Forecast By Distribution Channels, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Complementary and Alternative Medicine Market
13.1. Complementary and Alternative Medicine Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Complementary and Alternative Medicine Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. LKK Health Products Group Limited
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2023
14.1.3.2. LKK Health Products Group Limited 2023 Complementary and Alternative Medicine Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Pure Encapsulations, LLC.
14.3. Herb Pharm
14.4. Ramamani Iyengar Memorial Yoga Institute
14.5. Nordic Nutraceuticals
14.6. Columbia Nutritional
14.7. Helio USA Inc.
14.8. NatureKue
14.9. Herbal Hills
14.10. John Schumacher Unity Woods Yoga Centre
The complementary and alternative medicine market size was valued at USD 145.8 billion in 2023.
The CAGR of complementary and alternative medicine is 22.7% during the analysis period of 2024 to 2032.
The key players operating in the global market are including LKK Health Products Group Limited, Pure Encapsulations, LLC., Herb Pharm, Ramamani Iyengar Memorial Yoga Institute, Nordic Nutraceuticals, Columbia Nutritional, Helio USA Inc., NatureKue, Herbal Hills, and John Schumacher Unity Woods Yoga Centre.
Europe held the dominating position in complementary and alternative medicine industry during the analysis period of 2024 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of complementary and alternative medicine during the analysis period of 2024 to 2032.
The current trends and dynamics in the complementary and alternative medicine industry include increasing consumer awareness and acceptance of natural treatments, rising prevalence of chronic diseases, growing demand for holistic and preventive healthcare, and advances in research and validation of CAM practices.
The cancer disease held the maximum share of the complementary and alternative medicine industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date